What is the share price of Roselabs Finance Ltd (ROSELABS) today?
The share price of ROSELABS as on 23rd June 2025 is ₹30.24. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Roselabs Finance Ltd (ROSELABS) share?
The past returns of Roselabs Finance Ltd (ROSELABS) share are- Past 1 week: -2.90%
- Past 1 month: -1.94%
- Past 3 months: 7.23%
- Past 6 months: -10.27%
- Past 1 year: -8.36%
- Past 3 years: 134.42%
- Past 5 years: 133.87%
What are the peers or stocks similar to Roselabs Finance Ltd (ROSELABS)?
The peers or stocks similar to Roselabs Finance Ltd (ROSELABS) include:What is the market cap of Roselabs Finance Ltd (ROSELABS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Roselabs Finance Ltd (ROSELABS) is ₹30.24 Cr as of 23rd June 2025.What is the 52 week high and low of Roselabs Finance Ltd (ROSELABS) share?
The 52-week high of Roselabs Finance Ltd (ROSELABS) is ₹39.28 and the 52-week low is ₹25.45.What is the PE and PB ratio of Roselabs Finance Ltd (ROSELABS) stock?
The P/E (price-to-earnings) ratio of Roselabs Finance Ltd (ROSELABS) is -104.28. The P/B (price-to-book) ratio is -6.81.Which sector does Roselabs Finance Ltd (ROSELABS) belong to?
Roselabs Finance Ltd (ROSELABS) belongs to the Financials sector & Diversified Financials sub-sector.How to buy Roselabs Finance Ltd (ROSELABS) shares?
You can directly buy Roselabs Finance Ltd (ROSELABS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Roselabs Finance Ltd
ROSELABS Share Price
30.240.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ROSELABS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ROSELABS Performance & Key Metrics
ROSELABS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -104.28 | -6.81 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 16.89 | 2.54 | 1.17% |
ROSELABS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ROSELABS Company Profile
Roselabs Finance is a NBFC whose activities include non-banking financial services, including lending activities and equity/currency derivatives trading
ABCAPITAL
PE Ratio
20.73
20.73
1Y Return
13.30%
13.30%
Buy Reco %
100.00
100.00
MOTILALOFS
PE Ratio
19.99
19.99
1Y Return
32.81%
32.81%
Buy Reco %
100.00
100.00
CHOLAHLDNG
PE Ratio
17.24
17.24
1Y Return
58.72%
58.72%
Buy Reco %
100.00
100.00
PE Ratio
25.78
25.78
1Y Return
43.63%
43.63%
Buy Reco %
100.00
100.00
PE Ratio
52.18
52.18
1Y Return
29.64%
29.64%
Buy Reco %
16.67
16.67
ROSELABS Forecast
ROSELABS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ROSELABS
ROSELABS
Income
Balance Sheet
Cash Flow
Annual Normal View
ROSELABS Income Statement
ROSELABS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.38 | 3.82 | 0.02 | 0.00 | 0.16 | 0.00 | 2.75 | 1.18 | 0.73 | 0.72 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.02 | 1.01 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.22 | 0.11 | 0.06 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | ||||||||||||
| Selling & Administrative Expenses | 0.15 | 0.08 | 0.17 | 0.10 | 0.12 | 0.39 | 0.64 | 0.11 | ||||||||||||
| Operating & Other expenses | 1.51 | 2.62 | 0.05 | 0.00 | 2.76 | 0.00 | -0.00 | 1.15 | ||||||||||||
EBITDA | 0.50 | 1.01 | -0.26 | -0.14 | -2.75 | -0.44 | 2.06 | -0.13 | -0.29 | -0.29 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | 0.50 | 1.01 | -0.26 | -0.14 | -2.75 | -0.44 | 2.06 | -0.13 | -0.29 | -0.29 | ||||||||||
| Interest & Other Items | 1.94 | 1.65 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | -1.44 | -0.64 | -0.41 | -0.14 | -2.75 | -0.44 | 2.06 | -0.13 | -0.29 | -0.29 | ||||||||||
| Taxes & Other Items | 0.00 | -0.22 | -0.03 | 0.00 | -0.17 | 0.00 | 0.05 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -1.44 | -0.42 | -0.38 | -0.14 | -2.58 | -0.44 | 2.01 | -0.13 | -0.29 | -0.29 | ||||||||||
| EPS | -1.44 | -0.42 | -0.38 | -0.14 | -2.58 | -0.44 | 2.01 | -0.13 | -0.29 | -0.29 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ROSELABS Company Updates
ROSELABS Stock Peers
ROSELABS Past Performance & Peer Comparison
ROSELABS Past Performance & Peer Comparison
Comparing 3 stocks from
FinancialsDiversified Financials
Compare valuation-basic on Screener
FinancialsDiversified Financials
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Roselabs Finance Ltd | -104.28 | -6.81 | — |
| Aditya Birla Capital Ltd | 20.73 | 2.41 | — |
| Motilal Oswal Financial Services Ltd | 19.99 | 5.70 | 0.60% |
| Cholamandalam Financial Holdings Ltd | 17.24 | 1.69 | 0.07% |
ROSELABS Stock Price Comparison
Compare ROSELABS with any stock or ETFCompare ROSELABS with any stock or ETF
ROSELABS
ROSELABS Holdings
ROSELABS Shareholdings
ROSELABS Promoter Holdings Trend
ROSELABS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ROSELABS Institutional Holdings Trend
ROSELABS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ROSELABS Shareholding Pattern
ROSELABS Shareholding Pattern
ROSELABS Shareholding History
ROSELABS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ROSELABS stock
smallcases containing ROSELABS stock
Looks like this stock is not in any smallcase yet.
ROSELABS Events
ROSELABS Events
ROSELABS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSELABS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ROSELABS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSELABS has not given any dividends in last 5 years
ROSELABS Dividends
ROSELABS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeROSELABS Stock News & Opinions
ROSELABS Stock News & Opinions
Articles & Videos
Earnings
Roselabs Finance reports standalone net loss of Rs 0.05 crore in the March 2025 quarter
Net loss of Roselabs Finance reported to Rs 0.05 crore in the quarter ended March 2025. There were no net profit/loss reported during the previous quarter ended March 2024. Sales declined 37.72% to Rs 0.71 crore in the quarter ended March 2025 as against Rs 1.14 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net loss of Rs 0.13 crore during the previous year ended March 2024. Sales declined 37.72% to Rs 0.71 crore in the year ended March 2025 as against Rs 1.14 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.711.14 -38 0.711.14 -38 OPM %-7.04-2.63 --43.66-14.91 - PBDT-0.050 0 -0.29-0.13 -123 PBT-0.050 0 -0.29-0.13 -123 NP-0.050 0 -0.29-0.13 -123 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Roselabs Finance to table results
Roselabs Finance will hold a meeting of the Board of Directors of the Company on 18 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Roselabs Finance reports standalone net loss of Rs 0.11 crore in the December 2024 quarter
Net Loss of Roselabs Finance reported to Rs 0.11 crore in the quarter ended December 2024 as against net loss of Rs 0.03 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Roselabs Finance to discuss results
Roselabs Finance will hold a meeting of the Board of Directors of the Company on 17 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Roselabs Finance reports standalone net loss of Rs 0.09 crore in the September 2024 quarter
Net Loss of Roselabs Finance reported to Rs 0.09 crore in the quarter ended September 2024 as against net loss of Rs 0.05 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Roselabs Finance schedules board meeting
Roselabs Finance will hold a meeting of the Board of Directors of the Company on 18 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Roselabs Finance to convene AGM
Roselabs Finance announced that the 30th Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Roselabs Finance reports standalone net loss of Rs 0.04 crore in the June 2024 quarter
11 months agoBusiness Standard
Roselabs Finance reports standalone net loss of Rs 0.01 crore in the December 2022 quarter
2 years agoBusiness Standard
Roselabs Finance reports standalone net loss of Rs 0.39 crore in the September 2022 quarter
2 years agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of 126.03%, vs industry avg of 11.32%
Over the last 5 years, market share stayed at 0%